Month October 2024

MicroRNA Dysregulation in Alzheimer’s

Disease Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that affects millions of people worldwide. It is the most common form of dementia, characterized by progressive memory loss, cognitive decline, and changes in behavior and personality. While the exact cause…

Epigenetic Alterations in Alzheimer’s Disease

Alzheimer’s disease is a complex and devastating condition that currently affects over 5 million people in the United States alone. It is a progressive and irreversible brain disorder that gradually impairs memory, thinking, and behavior, leading to a loss of…

Oxidative Stress Markers in Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. It is the most common cause of dementia, accounting for 60-80% of all dementia cases. AD is characterized by the abnormal accumulation of amyloid-beta plaques and…

Mitochondrial Dysfunction in Alzheimer’s Neurons

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. It is the most common cause of dementia, accounting for approximately 60-80% of all cases. Despite extensive research, the exact cause of AD is still not…

Prion-Like Behavior of Amyloid-β in Alzheimer’s

Disease Alzheimer’s disease is a neurodegenerative disorder that affects millions of people worldwide. It is characterized by a progressive decline in cognitive function, memory loss, and changes in behavior. While the exact cause of Alzheimer’s disease is still unknown, scientists…

Tau Propagation Mechanisms in Alzheimer’s

Alzheimer’s is a devastating disease that affects millions of people worldwide. It is a progressive, degenerative brain disorder that causes memory loss, cognitive decline, and eventually leads to death. While the exact cause of Alzheimer’s is still unknown, scientists have…

Cerebral Amyloid Angiopathy in Alzheimer’s

Cerebral Amyloid Angiopathy (CAA) is a condition that affects the brain and is closely associated with Alzheimer’s disease. It is a progressive disorder that occurs when abnormal amyloid protein deposits build up in the walls of the blood vessels in…

Cerebral Microbleeds in Alzheimer’s Disease

Cerebral microbleeds (CMBs) are a common feature of Alzheimer’s disease, a progressive and degenerative brain disorder that affects millions of people worldwide. CMBs are small areas of bleeding in the brain that can often go unnoticed and are only visible…

Blood-Brain Barrier Integrity in Alzheimer’s

disease Alzheimer’s disease is a complex and debilitating neurodegenerative disorder that affects millions of people worldwide. It is the most common form of dementia, accounting for 60-70% of all cases. Alzheimer’s disease is characterized by the progressive loss of memory,…